Evidence map›Paper›PMID 40766874›Full record

ArticleBlood vessels, thrombosis & hemostasis2025

Cellular and enzymatic features of thrombi in humans are vascular bed dependent.

Matthew T Bender, Anu Aggarwal, Matthew Godwin, Suman Guntupalli, Aravinda Nanjundappa, Leben Tefera, Ihab Haddadin, Michael Tong, William M Baldwin, Robert L Fairchild and 6 more

Erratum issuedAbstract read
In one paragraph

Article in Blood vessels, thrombosis & hemostasis, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors.

Matthew T BenderDepartment of Neurological Surgery, University of Rochester, Rochester, NY.
Anu AggarwalDepartment of Cardiovascular and Metabolic Sciences, Lerner Research Institute, Cleveland, OH.
Matthew GodwinDepartment of Cardiovascular and Metabolic Sciences, Lerner Research Institute, Cleveland, OH.
Suman GuntupalliDepartment of Cardiovascular and Metabolic Sciences, Lerner Research Institute, Cleveland, OH.
Aravinda NanjundappaDepartment of Cardiovascular Medicine, Section of Interventional Cardiology, Heart Vascular and Thoracic Institute, Cleveland Clinic Foundation, Cleveland, OH.
Leben TeferaDepartment of Cardiovascular Medicine, Section of Vascular Medicine, Heart Vascular and Thoracic Institute, Cleveland Clinic Foundation, Cleveland, OH.
Ihab HaddadinDepartment of Radiology, Section of Interventional Radiology, Cleveland Clinic Foundation, Cleveland, OH.
Michael TongDepartment of Cardiac Surgery, Heart Vascular and Thoracic Institute, Cleveland Clinic Foundation, Cleveland, OH.
William M BaldwinDepartment of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH.
Robert L FairchildDepartment of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH.
Marcelo GomesDepartment of Cardiovascular Medicine, Section of Vascular Medicine, Heart Vascular and Thoracic Institute, Cleveland Clinic Foundation, Cleveland, OH.
Joseph CampbellDepartment of Cardiovascular Medicine, Section of Interventional Cardiology, Heart Vascular and Thoracic Institute, Cleveland Clinic Foundation, Cleveland, OH.
David SchumickDepartment of Cardiovascular and Metabolic Sciences, Lerner Research Institute, Cleveland, OH.
Pulkit ChaudhuryDepartment of Cardiovascular Medicine, Section of Vascular Medicine, Heart Vascular and Thoracic Institute, Cleveland Clinic Foundation, Cleveland, OH.
Doran MixDivision of Vascular Surgery, Department of Surgery, University of Rochester, Rochester, NY.
Scott J CameronDepartment of Cardiovascular and Metabolic Sciences, Lerner Research Institute, Cleveland, OH.

Funding

Noninvasive Markers and Transplant Outcome in HumansU01AI063594 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI HEEGER, PETER SCOTT · 2004 to 2022
$66.5M
Platelets as Biosensors and Mediators of Aortic Aneurysm GrowthR01HL158801 · NHLBI · CLEVELAND CLINIC LERNER COM-CWRU · PI CAMERON, SCOTT JAMES · 2021 to 2025
$2.5M
NHLBI NIH HHS R01 HL158801NIAID NIH HHS U01 AI063594
6 · The paper itself

Abstract

Mechanisms behind vascular remodeling following thrombosis are unclear. Although acute arterial thrombosis in the cerebrovascular circulation has devastating consequences and requires immediate attention, the management of venous thromboembolism (VTE) varies significantly. Our goal was to determine the molecular signatures and cellular content of thrombus extracted using a catheter to gain insight into vascular remodeling. Twenty-five patients underwent catheter-directed thrombectomy (CDT); 13 for cerebrovascular accident (CVA), 8 for pulmonary embolism, and 4 for deep vein thrombosis. Protein and RNA were extracted from thrombi to enable immunoblotting, RNA sequencing, and quantification of gene expression. The time from symptom onset to thrombus extraction was 7.7 ± 1.9 hours for CVA and 109 ± 55 hours for VTE. Protein concentration, white blood cell content (monocytes), and red blood cell content were greater in venous thrombus than in arterial thrombus, whereas the platelet content was similar. Both venous and arterial thrombi contained several zinc endopeptidases belonging to the matrix metalloproteinase (MMP) family. MMP9 activity in venous thrombus was greater than arterial thrombus (61 ± 9 ng/mL per μg protein vs 25 ± 6 ng/mL per μg protein;

Identifiers

PMID40766874
PMCPMC12320401

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.